BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 18, 2013
View Archived Issues
Dalesconol B exerts neuroprotective effects, attenuates memory deficits in models of Alzheimer's
Read More
A novel glycooptimized biobetter of cetuximab is well tolerated in first-in-human trials
Read More
Research gives insight into miR-17-5p's role in the pathogenesis of pediatric SLE
Read More
Oncodesign's IMODI project wins award from French government
Read More
Anti-osteopontin antibodies as a new therapeutic approach to MS
Read More
Volociximab administered with ranibizumab in phase I/II trial
Read More
Targeting DNA repair with ATX-101 for enhancing sensitivity to anticancer drugs
Read More
AMAG Pharmaceuticals reports preliminary data from ferumoxytol extension study
Read More
Diffusion Pharmaceuticals completes enrollment in phase II trans-sodium crocetinate trial
Read More
LDK-378 receives FDA breakthrough therapy designation for NSCLC
Read More
Omni Bio Pharmaceutical reports preclinical results for Fc-AAT
Read More
Ocriplasmin approved for treating vitreomacular traction in the E.U.
Read More
Novel CETP inhibitors patented at Merck & Co.
Read More
GlaxoSmithKline presents new FAS inhibitors
Read More
Merck & Co. announces novel beta-secretase inhibitors
Read More
Chinese investigators divulge new cancer therapies
Read More
Novel serotonin 5-HT transporter inhibitors disclosed by Danish group
Read More
Gelna Biopharma acquires U.S. rights to Abstral
Read More
Intravesical imiquimod found safe and feasible as intravesical therapy for bladder cancer
Read More
R-Tech Ueno begins enrollment in phase III study of unoprostone for retinitis pigmentosa
Read More
Merck KGaA and Nordic Bioscience form alliance to develop treatment for osteoarthritis of the knee
Read More
BIIB-037 well tolerated in patients with Alzheimer's disease
Read More
Harvard's Wyss Institute and Sony DADC enter collaboration for Organs-on-Chips technologies
Read More
OphthaliX completes patient enrollment for international phase III trial in dry eye syndrome
Read More
